Mer­ck inks deal with Un­nat­ur­al Prod­ucts; CG On­col­o­gy’s up­sized IPO; Lo­cus gets $24M from BAR­DA

Plus, news about Out­look Ther­a­peu­tics and Adicet Bio:

Mer­ck and Un­nat­ur­al Prod­ucts col­lab­o­rate: Per the deal, Mer­ck will make an undis­closed up­front pay­ment to the San­ta Cruz, CA-based biotech and up to $220 mil­lion in mile­stones. The com­pa­nies plan to de­vel­op macro­cyclic ther­a­pies for can­cer. — Jaimy Lee

CG On­col­o­gy up­sizes IPO: The Phase III blad­der can­cer biotech in­creased its of­fer­ing size from 11.8 mil­lion shares to 17 mil­lion shares $CGON, per a SEC fil­ing on Tues­day. At the mid-point of its price range of $17.00, CG would raise about $262.8 mil­lion in its Nas­daq de­but lat­er this month. It set out a $181 mil­lion tar­get last week. — Kyle LaHu­cik

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER